Category: ROOT

48% of physicians are happy at work, survey finds 

Physicians’ happiness fell amid the pandemic and is not rebounding easily, according to Medscape’s 2023 Physician Lifestyle and Happiness Report.

Over half of physicians would take pay cut for more work-life balance, report says

Over half of U.S. physicians (53 percent) reported that they would take a pay cut for improved work-life balance, according to Medscape’s Jan. 20 “Lifestyle and Happiness Report 2023.” 

Physicians are unhappier now than before the pandemic: Medscape

Medscape’s 2023 “Physician Lifestyle and Happiness Report” found that physicians’ happiness outside of work is below pre-pandemic levels. 

FTC asks for Shkreli to be held in contempt

The infamous “Pharma Bro” Martin Shkreli should be held in contempt for opening another drug company, the Federal Trade Commission urged a federal judge Jan. 20. 

Lourdes Health taps CEO

Pasco, Wash.-based Lourdes Health has named Mark Holyoak, BSN, its new CEO. 

CEO, CFO resign from California hospital

The acting CEO and acting CFO of El Centro (Calif.) Regional Medical Center have resigned from their positions after the hospital’s board accepted a termination notice from its management company. 

Hospitals have more questions than answers on noncompetes amid FTC proposal

The Federal Trade Commission on Jan. 5 issued a proposed rule that would ban noncompete agreements, but whether that rule will apply to nonprofit hospitals is unclear. 

Inspira Health cuts ribbon on Salem Medical Center ASC

Vineland, N.J.-based Inspira Health held a ribbon-cutting on Jan. 20 to add the Salem (N.J.) Medical Center and its affiliated hospital building and ASC to its network, according to a Jan. 20 report from NJ.com.

Payers splitting with health systems: How ASCs could be affected 

Contract disputes and payer splits are threatening coverage nationwide, and some ASCs are being affected by the parties unable to meet year-end or looming deadlines. 

NYU Langone Health exits diabetes vaccine trial

Researchers from New York City-based NYU Langone Health departed from a trial investigating a tuberculosis vaccine’s potential as a pediatric Type 1 diabetes vaccine, The New York Times reported Jan. 20.